Letrozole Tablet
Product Images NDC 51991-759

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Letrozole (NDC 51991-759). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Letrozole 01)

FDA Label Image

Figure 1 (Letrozole 02)

Figure 1 (Letrozole 02)
This is a data table comparing the effectiveness of Letrozole and Tamoxifen treatments on a group of patients. The table shows the number of patients and the percentage of events (responses to treatment) for each treatment option. The data provided also shows the number of patients censored (uncompleted treatment) for each treatment. The data is plotted over a period of 72 months, and shows the number of patients still under observation at each milestone.*
FDA Label Image

Figure 2 (Letrozole 03)

Figure 2 (Letrozole 03)
This text is not enough to generate a useful description.*
FDA Label Image

Figure 3 (Letrozole 04)

FDA Label Image

Figure 4 (Letrozole 05)

FDA Label Image

Figure 5 (Letrozole 06)

Figure 5 (Letrozole 06)
This is a table depicting the "Time to Progression" (in days) for a treatment group that used Letrozole Tablets 0.5 mg. The table has values ranging from 0 to 1000 and the headers consist of T's and numbers indicating the number of days. The tablets used in this study were Letrozole Tablets 25mg-AG.*
FDA Label Image

Principal Display Panel (2.5 mg Tablet Bottle Label)

Principal Display Panel (2.5 mg Tablet Bottle Label)
Letrozole Tablets, USP is a medication with each film-coated tablet containing 2.5 mg Letrozole USP. The dosage should be checked in the package insert and it should be stored in a USP controlled room temperature of 25°C with excursions permitted to 15-30°C. The drug should be kept out of children's reach. The tablet is distributed by Breckenridge Pharmaceutical and manufactured by Natco Pharma Limited in India. The other information is not legible due to unclear output.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.